Back
AptarGroup Vs. Aligos Therapeutics Industry Stock Comparison
Sell
31
ATR
AptarGroup
Last Price:
$159.03
Seasonality Move:
2.85%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.38
Seasonality Move:
7.18%
Sell
31
AptarGroup (ATR)
is a Sell
Is AptarGroup a Buy, Sell or Hold?
-
The current AptarGroup [ATR] share price is $158.87. The Score for ATR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
ATR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATR Stock Price Chart
What is AptarGroup's stock price today?
-
The AptarGroup share price today is $158.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATR is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.85 | Sell |
Relative Strength Index (14 RSI): | 26.04 | Sell |
Chaikin Money Flow: | -239132 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (165.4 - 173.58) | Sell |
Bollinger Bands (100): | (150.17 - 170.37) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.1 | Buy |
Relative Strength Index (14 RSI): | 79.33 | Buy |
Chaikin Money Flow: | 265554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.3 - 32.5) | Buy |
Bollinger Bands (100): | (7.16 - 22.66) | Buy |
ATR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 166.61 | Sell |
20-day SMA: | 169.71 | Sell |
50-day SMA: | 169.14 | Sell |
200-day SMA: | 152.11 | Buy |
8-day EMA: | 164.78 | Sell |
20-day EMA: | 167.98 | Sell |
50-day EMA: | 166.98 | Sell |
200-day EMA: | 153.48 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 28.23 | Buy |
50-day SMA: | 17.95 | Buy |
200-day SMA: | 16.14 | Buy |
8-day EMA: | 33.62 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 21.66 | Buy |
200-day EMA: | 17.2 | Buy |
AptarGroup Earnings Growth & ATR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.53 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
AptarGroup Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |